Skip to main content
logo
OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.070
+0.120 (3.04%)
At close: Sep 11, 2026, 4:00 PM EDT
4.010
-0.060 (-1.47%)
After-hours: Sep 11, 2026, 7:30 PM EDT

OmniAb Revenue

OmniAb had revenue of $13.42M in the quarter ending June 30, 2026, with 244.24% growth. This brings the company's revenue in the last twelve months to $38.46M, up 67.01% year-over-year. In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%.

Revenue (ttm)
$38.46M
Revenue Growth
+67.01%
P/S Ratio
15.39
Revenue / Employee
$432,101
Employees
89
Market Cap
591.74M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202518.67M-7.73M-29.27%
Dec 31, 202426.39M-7.77M-22.75%
Dec 31, 202334.16M-24.91M-42.17%
Dec 31, 202259.08M24.33M70.02%
Dec 31, 202134.75M11.48M49.34%
Dec 31, 202023.27M4.95M27.02%
Dec 31, 201918.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix462.25M
Arvinas316.70M
REGENXBIO174.48M
Assembly Biosciences74.85M
Scribe Therapeutics33.30M
Allogene Therapeutics4.64M
Prime Medicine4.07M
Shattuck Labs1.00M
Revenue Rankings

OABI News

More News